Paniculitis granulomatosa sarcoidal asociada a inhibidores de puntos de control inmunológico: un evento adverso cutáneo inmunomediado poco frecuente

Immune checkpoint inhibitors (ICIs), or checkpoint inhibitors, have been associated with various inflammatory and autoimmune adverse effects, known as immune-related adverse events (irAEs). Among irAEs, dermatological toxicities are the most prevalent, with maculopapular rash, pruritus, and lichenoid and psoriasiform eruptions being the most common.